Bexarotene Amyloid Treatment for Alzheimer's Disease

NCT01782742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Bexarotene
DRUG: Placebo

Sponsor

The Cleveland Clinic